HIV plays a direct role in causing blood cell cancers in rare instances, says a new study of HIV and tumor DNA.…

The spike protein critical for coronavirus research -- and for some COVID-19 vaccines -- slowly…

All News

Date Posted Range

Frederick National Laboratory Staff Advance Genomic Data Commons Capabilities

Posted 3/15/2018
FREDERICK, Md. -- A recent study that examined how mutations of a certain gene could affect clinical management of glioma, one of the most common types of primary brain tumors, is one of the first examples of the Genomic Data Commons’ impact on cancer research.

Launched in 2016 as part of the Precision Medicine Initiative, the National Cancer Institute’s Genomic…

Nanotechnology Characterization Laboratory Unveils New Technical Services for Drug Developers

Posted 3/8/2018
FREDERICK, Md. -- Drug developers now have access to a shared analytical technology, developed and provided by the Frederick National Laboratory for Cancer Research, that helps fine-tune nanomedicine formulations and overcomes a key hurdle on the path toward Food and Drug Administration approval of effective new therapies and generic versions of nanomedicines.

Frederick National Laboratory and Georgetown University Launch Research and Education Collaboration

Posted 2/27/2018
FREDERICK, Md. -- A new collaboration established between Georgetown University and the Frederick National Laboratory for Cancer Research aims to expand both institutions’ research and training missions in the biomedical sciences.

Representatives from Georgetown and the Frederick National Laboratory signed a memorandum of understanding that paves the way for…

First-in-Class Drug Being Tested for Breast Cancer May Also Work in Lung Cancer

Posted 2/7/2018
FREDERICK, Md. -- A novel agent now being tested in human clinical trials of breast and other cancers may also prove to be a candidate for treating lung cancer, the No. 1 cancer killer worldwide.

The targeted treatment uses a new approach to destroy cancer cells. It attacks the basic machinery that malignant cells use to reproduce themselves. The machinery…

Study IDs Genetic Markers that Speed AIDS Progression

Posted 1/25/2018
A study published in the journal Science sheds new light on how a set of human genes can accelerate progression of AIDS-related illness in people living with HIV who are not on treatment.

South African scientists led the international research team, which included Frederick National Laboratory scientists, that involved 9,763 people with HIV in the United States…

Experimental MERS Treatment Deemed Safe in Phase I Clinical Trial

Posted 1/9/2018
FREDERICK, Md. -- A small clinical study overseen by the National Institute of Allergy and Infectious Diseases (NIAID) with support from the Frederick National Laboratory for Cancer Research has found that an experimental treatment for Middle East Respiratory Syndrome (MERS), an illness for which there is no licensed vaccine or treatment, is safe and well-tolerated in healthy…

New Partnership Seeks to Increase Availability of Lifesaving Transplants

Posted 11/28/2017
The Frederick National Laboratory for Cancer Research has entered into a new partnership with Fred Hutchinson Cancer Research Center that if successful, could improve current methods of donor selection and thereby make lifesaving transplant procedures more readily available for patients with leukemia, multiple myeloma, and other disorders.

For patients with…

Public-Private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One

Posted 10/26/2017
Scientists from two U.S. national laboratories, industry, and academia today launched an unprecedented effort to transform the way cancer drugs are discovered by creating an open and sharable platform that integrates high-performance computing, shared biological data from public and industry sources, and emerging biotechnologies to dramatically accelerate the discovery of…

Change in Leadership at the Frederick National Laboratory

Posted 10/26/2017
RESTON, Va., Oct. 26, 2017 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology company, announced today that Ethan Dmitrovsky, M.D. was appointed President of subsidiary Leidos Biomedical Research, Inc. (Leidos Biomed) and Laboratory Director of the Frederick National Laboratory for Cancer Research (FNLCR). Dmitrovsky will succeed current President David…

Plasma Treatment for Severe Influenza Deemed Well-Tolerated in Clinical Study

Posted 9/27/2017
The upcoming flu season is just around the corner, and an ongoing challenge for researchers has been how to best respond to cases of severe influenza in the event of an outbreak.

The Frederick National Laboratory for Cancer Research has helped the National Institute of Allergy and Infectious Diseases (NIAID) to coordinate a clinical trial to determine if immune…

Media Inquiries

For all media related questions please contact:

A portrait photo
Mary Ellen Hackett Manager, Communications Office 301-401-8670